Profile data is unavailable for this security.
About the company
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.
- Revenue in USD (TTM)3.24bn
- Net income in USD304.90m
- Incorporated2000
- Employees9.71k
- LocationBruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
- Phone+1 (978) 663-3660
- Fax+1 (978) 663-5585
- Websitehttps://www.bruker.com/
More ▼
Mergers & acquisitions
| Acquired company | BRKR:NSQ since announced | Transaction value |
|---|---|---|
| Dynamic Biosensors GmbH | -14.51% | -- |
| NanoString Technologies Inc | -31.97% | 392.60m |
| Nanophoton Corp | -22.75% | -- |
| Spectral Instruments Imaging LLC | -20.53% | -- |
| Chemspeed Technologies AG | -20.22% | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procept Biorobotics Corp | 199.84m | -100.06m | 5.06bn | 626.00 | -- | 20.23 | -- | 25.32 | -1.95 | -1.95 | 3.89 | 4.63 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Inspire Medical Systems Inc | 755.59m | 33.05m | 5.66bn | 1.01k | 173.44 | 8.12 | 148.82 | 7.49 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Stevanato Group SpA | 1.14bn | 119.48m | 5.95bn | 5.64k | 44.16 | 3.89 | 29.58 | 5.22 | 0.4449 | 0.4449 | 4.23 | 5.05 | 0.5284 | 2.75 | 2.66 | 202,254.00 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Merit Medical Systems Inc | 1.33bn | 120.04m | 6.14bn | 6.95k | 51.60 | 4.64 | 28.19 | 4.63 | 2.04 | 2.04 | 22.55 | 22.71 | 0.6334 | 2.29 | 7.41 | 190,772.80 | 5.73 | 2.45 | 6.32 | 2.77 | 46.83 | 44.50 | 9.05 | 3.91 | 3.82 | 31.88 | 0.3619 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Lantheus Holdings Inc | 1.50bn | 427.61m | 6.29bn | 834.00 | 15.04 | 5.33 | 12.84 | 4.20 | 6.02 | 6.02 | 21.09 | 16.97 | 0.8383 | 8.28 | 5.09 | 1,794,723.00 | 23.95 | 6.69 | 32.76 | 7.73 | 64.78 | 57.56 | 28.57 | 9.02 | 1.56 | -- | 0.324 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Glaukos Corp | 360.35m | -149.57m | 7.94bn | 907.00 | -- | 11.87 | -- | 22.03 | -2.96 | -2.96 | 7.06 | 12.13 | 0.3843 | 1.69 | 7.53 | 397,295.50 | -15.95 | -8.73 | -17.23 | -9.35 | 76.61 | 74.77 | -41.51 | -28.69 | 4.71 | -311.24 | 0.1591 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Repligen Corp | 622.64m | -17.13m | 7.99bn | 1.78k | -- | 3.96 | 155.61 | 12.83 | -0.3079 | -0.3079 | 11.09 | 36.00 | 0.233 | 1.57 | 5.29 | 349,206.40 | -0.6411 | 4.38 | -0.7032 | 5.03 | 50.37 | 55.43 | -2.75 | 15.91 | 8.76 | -- | 0.2055 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Bruker Corp | 3.24bn | 304.90m | 8.65bn | 9.71k | 27.52 | 4.79 | 18.33 | 2.67 | 2.07 | 2.07 | 21.89 | 11.92 | 0.6527 | 1.51 | 5.73 | 333,913.70 | 6.12 | 8.38 | 8.14 | 11.40 | 49.31 | 49.85 | 9.38 | 11.39 | 0.7085 | 26.83 | 0.5549 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Teleflex Inc | 3.03bn | 238.01m | 8.90bn | 14.50k | 38.01 | 1.99 | 17.63 | 2.94 | 5.04 | 5.03 | 64.01 | 96.50 | 0.404 | 2.11 | 6.76 | 208,677.50 | 3.18 | 5.86 | 3.46 | 6.42 | 55.99 | 54.43 | 7.87 | 14.62 | 1.39 | 6.61 | 0.2818 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Masimo Corp | 2.04bn | 78.60m | 9.26bn | 3.80k | 118.96 | 6.32 | 53.44 | 4.53 | 1.45 | 1.45 | 37.72 | 27.35 | 0.6715 | 1.77 | 5.52 | 537,526.30 | 2.58 | 8.65 | 3.23 | 10.31 | 50.05 | 57.30 | 3.85 | 12.03 | 1.11 | 2.84 | 0.3456 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Bio Rad Laboratories Inc | 2.58bn | -778.69m | 9.33bn | 8.03k | -- | 1.24 | -- | 3.62 | -27.32 | -27.32 | 90.77 | 267.46 | 0.2294 | 1.49 | 5.61 | 321,321.20 | -6.92 | 9.08 | -7.26 | 9.60 | 54.43 | 55.55 | -30.18 | 41.97 | 4.52 | 0.2612 | 0.1383 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| Henry Schein, Inc. | 12.50bn | 314.00m | 9.36bn | 25.00k | 30.74 | 2.68 | 15.81 | 0.749 | 2.44 | 2.44 | 96.89 | 27.99 | 1.22 | 4.77 | 7.73 | 499,960.00 | 2.97 | 6.09 | 4.86 | 10.44 | 31.59 | 30.04 | 2.42 | 4.40 | 0.817 | 6.23 | 0.348 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Penumbra Inc | 1.16bn | 34.55m | 9.40bn | 4.20k | 284.62 | 8.51 | 154.30 | 8.07 | 0.8602 | 0.8602 | 29.71 | 28.78 | 0.7897 | 1.04 | 6.08 | 277,089.50 | 2.34 | 2.32 | 2.61 | 2.61 | 65.70 | 63.90 | 2.97 | 3.17 | 3.25 | -- | 0.0218 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Solventum Corp | 8.22bn | 720.00m | 12.23bn | 22.01k | 17.01 | 3.83 | 9.68 | 1.49 | 4.16 | 4.16 | 47.45 | 18.48 | 0.5831 | 3.93 | 7.19 | 373,290.30 | 5.11 | -- | 6.03 | -- | 56.38 | -- | 8.76 | -- | 0.8268 | 5.02 | 0.7176 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Bruker Corp's reporting currency: US Dollar USD
48.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 13.04m | 8.61% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 12.98m | 8.57% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 10.53m | 6.95% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 9.91m | 6.55% |
| Pallas Capital Advisors LLCas of 30 Sep 2024 | 8.02m | 5.30% |
| Massachusetts Financial Services Co.as of 30 Sep 2024 | 5.46m | 3.61% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 3.63m | 2.40% |
| AllianceBernstein LPas of 30 Sep 2024 | 3.55m | 2.34% |
| RTW Investments LPas of 30 Sep 2024 | 3.48m | 2.30% |
| MFS International (UK) Ltd.as of 31 Oct 2024 | 3.04m | 2.01% |
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
